Related references
Note: Only part of the references are listed.Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease
Lauren Pickel et al.
ADVANCES IN NUTRITION (2022)
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study
Godela M. Brosnahan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2022)
Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model
Nuria M. Pastor-Soler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2022)
Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53
Peng Jiang et al.
MOLECULAR CELL (2021)
Overweight and Obesity and Progression of ADPKD
Kristen L. Nowak et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)
Ronald D. Perrone et al.
KIDNEY INTERNATIONAL (2021)
Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease
Alfons Segarra-Medrano et al.
CLINICAL KIDNEY JOURNAL (2020)
Metabolic reprogramming and the role of mitochondria in polycystic kidney disease
Christine Podrini et al.
CELLULAR SIGNALLING (2020)
Abstract 104: Mortality Risk Across Chronic Kidney Disease Stages With Fibrate or Niacin Use Compared With No Fibrate or Niacin Therapy in Male US Veterans
Melissa Soohoo et al.
(2020)
The role of PPARα in autosomal dominant polycystic kidney disease
Ronak Lakhia
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney disease
Xuewen Song et al.
CELLULAR SIGNALLING (2020)
Role of chemokines, innate and adaptive immunity
Kurt A. Zimmerman et al.
CELLULAR SIGNALLING (2020)
Metabolic Changes in Polycystic Kidney Disease as a Potential Target for Systemic Treatment
Sophie Haumann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease
Eun Ji Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
AMP-activated protein kinase: the current landscape for drug development
Gregory R. Steinberg et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Polycystin 2 regulates mitochondrial Ca2+ signaling, bioenergetics, and dynamics through mitofusin 2
Ivana Y. Kuo et al.
SCIENCE SIGNALING (2019)
A single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease
Bogdan Marian Sorohan et al.
BMC NEPHROLOGY (2019)
Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease
Wouter N. Leonhard et al.
EBIOMEDICINE (2019)
The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease
Xiaoying Lian et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
mTOR: A Cellular Regulator Interface in Health and Disease
Fahd Boutouja et al.
CELLS (2019)
Mitochondrial Dysfunction in Adipocytes as a Primary Cause of Adipose Tissue Inflammation
Chang-Yun Woo et al.
DIABETES & METABOLISM JOURNAL (2019)
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease
Kristen L. Nowak et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue
Peng Zhao et al.
CELL (2018)
Cilia-localized LKB1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney
Amandine Viau et al.
EMBO JOURNAL (2018)
Obesity Pathophysiology and Management
Kishore M. Gadde et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Mitochondrial dysfunction in obesity
Aline Haas de Mello et al.
LIFE SCIENCES (2018)
GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis
Chengshi Wang et al.
PLOS ONE (2018)
A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed
Cheng-Chao Lin et al.
SCIENTIFIC REPORTS (2018)
Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in Pkd1-Deficient Mice
Yang Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing
Matthew B. Lanktree et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease
Marcelo F. Cassini et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Are Cyst-Associated Macrophages in Polycystic Kidney Disease the Equivalent to TAMs in Cancer?
Thomas Weimbs
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Metabolism and mitochondria in polycystic kidney disease research and therapy
Valeria Padovano et al.
NATURE REVIEWS NEPHROLOGY (2018)
Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression
A. Lianne Messchendorp et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways
Christine Podrini et al.
COMMUNICATIONS BIOLOGY (2018)
PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice
Ronak Lakhia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney
Takeshi Yamamoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Recent Advances in Human Genetics and Epigenetics of Adiposity: Pathway to Precision Medicine?
Tove Fall et al.
GASTROENTEROLOGY (2017)
Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathys
Christopher T. Salatto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults
Majid Ezzati et al.
LANCET (2017)
Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
Yu Ishimoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function
Valeria Padovano et al.
MOLECULAR BIOLOGY OF THE CELL (2017)
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Health Effects of Overweight and Obesity in 195 Countries over 25 Years
Ashkan Afshin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
Sachin Hajarnis et al.
NATURE COMMUNICATIONS (2017)
The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
Mee-Sup Yoon
NUTRIENTS (2017)
Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
Ming-Yang Chang et al.
SCIENTIFIC REPORTS (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
The changes in glucose metabolism and cell proliferation in the kidneys of polycystic kidney disease mini-pig models
Xiaoying Lian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Role of Mitochondrial Dysfunction in Hypertension and Obesity
Vicente Lahera et al.
CURRENT HYPERTENSION REPORTS (2017)
2-Deoxy-D-Glucose Ameliorates PKD Progression
Marco Chiaravalli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Food Restriction Ameliorates the Development of Polycystic Kidney Disease
Gina Warner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease
Ronak Lakhia et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease
Young-Hwan Hwang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function
Emilio P. Mottillo et al.
CELL METABOLISM (2016)
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4
Piero Ruggenenti et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease
Christina M. Heyer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury
Hazel H. Szeto et al.
KIDNEY INTERNATIONAL (2016)
Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice
Jongkil Kim et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease
Luis F. Menezes et al.
EBIOMEDICINE (2016)
Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease
Meliana Riwanto et al.
PLOS ONE (2016)
AMPK Activation of Muscle Autophagy Prevents Fasting-Induced Hypoglycemia and Myopathy during Aging
Adam L. Bujak et al.
CELL METABOLISM (2015)
Proteomics of Primary Cilia by Proximity Labeling
David U. Mick et al.
DEVELOPMENTAL CELL (2015)
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease
Li Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Pulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trial
Markus Riegersperger et al.
TRIALS (2015)
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
Hyun Mi Kang et al.
NATURE MEDICINE (2015)
Mitochondrial dysfunction and insulin resistance: an update
Magdalene K. Montgomery et al.
ENDOCRINE CONNECTIONS (2015)
Insulin inhibits AMPK activity and phosphorylates AMPK Ser485/491 through Akt in hepatocytes, myotubes and incubated rat skeletal muscle
Rudy J. Valentine et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Local Proliferation of Macrophages Contributes to Obesity-Associated Adipose Tissue Inflammation
Shinya U. Amano et al.
CELL METABOLISM (2014)
Low-Dose Rapamycin ( Sirolimus) Effects in Autosomal Dominant Polycystic Kidney Disease: An Open-Label Randomized Controlled Pilot Study
William E. Braun et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury
Anne-Emilie Decleves et al.
KIDNEY INTERNATIONAL (2014)
Defective metabolism in polycystic kidney disease: potential for therapy and open questions
Isaline Rowe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1 alpha axis in db/db mice
M. Y. Kim et al.
DIABETOLOGIA (2013)
Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease
Xia Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Type of PKD1 Mutation Influences Renal Outcome in ADPKD
Emilie Cornec-Le Gall et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Obesity-Mediated Autophagy Insufficiency Exacerbates Proteinuria-induced Tubulointerstitial Lesions
Kosuke Yamahara et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Macrophages promote polycystic kidney disease progression
Katherine I. Swenson-Fields et al.
KIDNEY INTERNATIONAL (2013)
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
Isaline Rowe et al.
NATURE MEDICINE (2013)
Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice
Myriam Aouadi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
Arlene B. Chapman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Increased Macrophage Migration Into Adipose Tissue in Obese Mice
Da Young Oh et al.
DIABETES (2012)
Effects of Fibrates in Kidney Disease
Min Jun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease
Berenice Reed et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Network Analysis of a Pkd1-Mouse Model of Autosomal Dominant Polycystic Kidney Disease Identifies HNF4α as a Disease Modifier
Luis F. Menezes et al.
PLOS GENETICS (2012)
Urinary monocyte chemoattractant protein-1 in renal disease
Min Jeong Kim et al.
CLINICA CHIMICA ACTA (2011)
Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin
Raj S. Padwal et al.
DIABETES CARE (2011)
Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
Sandra Galic et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Macrophages Promote Cyst Growth in Polycystic Kidney Disease
Anil Karihaloo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat Diet
Anne-Emilie Decleves et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis
Yuki Tanaka et al.
KIDNEY INTERNATIONAL (2011)
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
Maria V. Irazabal et al.
KIDNEY INTERNATIONAL (2011)
Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
Vinita Takiar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mitochondrial dysfunction in obesity
Juan C Bournat et al.
Current Opinion in Endocrinology Diabetes and Obesity (2011)
Association of Urinary Biomarkers With Disease Severity in Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-sectional Analysis
Esther Meijer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
PPARs: diverse regulators in energy metabolism and metabolic diseases
Yong-Xu Wang
CELL RESEARCH (2010)
Rapamycin Ameliorates PKD Resulting from Conditional Inactivation of Pkd1
Jonathan M. Shillingford et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Sirolimus Therapy to Halt the Progression of ADPKD
Norberto Perico et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease
Iram Zafar et al.
KIDNEY INTERNATIONAL (2010)
Primary cilia regulate mTORC1 activity and cell size through Lkb1
Christopher Boehlke et al.
NATURE CELL BIOLOGY (2010)
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Role of the energy sensor AMP-activated protein kinase in renal physiology and disease
Kenneth R. Hallows et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Polycystic Kidney Disease
Peter C. Harris et al.
ANNUAL REVIEW OF MEDICINE (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Family History of Renal Disease Severity Predicts the Mutated Gene in ADPKD
Moumita Barua et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Metabolic Syndrome Components in Patients with Autosomal-Dominant Polycystic Kidney Disease
Maria Pietrzak-Nowacka et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2009)
Polycystin-1 Regulates Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Tuberin To Control Cell Size through mTOR and Its Downstream Effectors S6K and 4EBP1
Gianfranco Distefano et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
Bin Zheng et al.
MOLECULAR CELL (2009)
Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)
Iram Zafar et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Cellular hypoxia and adipose tissue dysfunction in obesity
I. Stuart Wood et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Autosomal dominant polycystic kidney disease
Jared J. Grantham
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Lipid accumulation in non-adipose tissue and lipotoxicity
N. A. van Herpen et al.
PHYSIOLOGY & BEHAVIOR (2008)
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease
Sandro Rossetti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease
Ming Wu et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2007)
Adipocytes as regulators of energy balance and glucose homeostasis
Evan D. Rosen et al.
NATURE (2006)
Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling
Gregory R. Steinberg et al.
CELL METABOLISM (2006)
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance
Nozomu Kamei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters
C-S Kim et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects
Gautam K. Bandyopadhyay et al.
DIABETES (2006)
Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle
Tonya L. Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of AMP-activated protein kinase in mitochondrial biogenesis
Richard M. Reznick et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
LKB1-AMPK signaling in muscle from obese insulin-resistant Zucker rats and effects of training
A Sriwijitkamol et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease
JM Shillingford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)
PR Wahl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
GV Thomas et al.
NATURE MEDICINE (2006)
Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality
S Fraser et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone
MY Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease
YX Tao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function
DP Kelly et al.
GENES & DEVELOPMENT (2004)
AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females
GR Steinberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor α by AMP-activated protein kinase
M Bronner et al.
BIOCHEMICAL JOURNAL (2004)
Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition
X Yu et al.
DIABETOLOGIA (2004)
Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease
D Zheng et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease
RW Schrier et al.
KIDNEY INTERNATIONAL (2003)
Isoform-specific regulation of 5′ AMP-activated protein kinase in skeletal muscle from obese Zucker (fa/fa) rats in response to contraction
BR Barnes et al.
DIABETES (2002)
Accelerated publication -: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc
RC Osthus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
High dietary fat intake increases renal cyst disease progression in Han : SPRD-cy rats
S Jayapalan et al.
JOURNAL OF NUTRITION (2000)
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
RB Vega et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
